Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Novartis nominates ex-BMS chief Caforio as its next chair
Giovanni Caforio is known for striking some of the industry’s largest M&As, including BMS' $74 billion acquisition of Celgene in 2019.
Angus Liu
Apr 23, 2024 2:44am
Sponsored
3 Principles to Optimize Patient Support Programs
Apr 22, 2024 8:00am
Orphan drug market to reach $270B by 2028: Evaluate
Apr 24, 2024 12:01am
Sponsored
MAIC Methodology Matters: Comparing BRUKINSA vs Acalabrutinib in R/R CLL
Apr 1, 2024 8:00am
Day One pressures Novartis with FDA nod for novel RAF inhibitor
Apr 23, 2024 10:13pm
Novartis gears up for key expansions of 3 cancer drugs
Apr 23, 2024 3:37pm
Marketing News
The Bloc taps Ogilvy, McCann alum as associate creative director
Apr 23, 2024 11:25am
Life sci consulting firm Santander makes its debut
Apr 23, 2024 10:40am
Leqembi launch hamstrung by physicians' 'therapeutic nihilism'
Apr 23, 2024 9:50am
Inizio Evoke Comms alum DeViteri returns as North American prez
Apr 23, 2024 7:45am
See More Marketing News